12/25/2021,"The Food and Drug Administration’s authorization of Pfizer (ticker: PFE) Covid-19 pill Paxlovid on Wednesday offered some hope. The authorization represents an extraordinary coup for Pfizer, its second of the pandemic. Analysts expect Pfizer to sell $21.7 billion worth of the drug in 2022, according to FactSet, though the company now says that it will make 120 million courses of the drug next year, 40 million more than previously forecast, which will probably drive those estimates higher.",Business/Barrons.com•yesterday,Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.,https://finance.yahoo.com/m/5eb4fba3-2e81-3ccb-9234-07ddb8dec04b/pfizer%E2%80%99s-covid-pill-gets.html
